Antimicrob Agents Chemother

1. YU Y, Chen S, Zhang H, Duan Y, et al
   A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection.
   Antimicrob Agents Chemother. 2024 Mar 12:e0135023. doi: 10.1128/aac.01350.
   

   >> Share

   
   

   
   Arch Virol

2. YUAN J, Pan J, Zhang X, Gao R, et al
   TRIM21 reduces H1N1-induced inflammation and apoptosis by regulating the TBK1-IRF3 signaling pathway in A549 cells.
   Arch Virol. 2024;169:74.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. KIM HJ, Han CW, Jeong MS, Jang SB, et al
   Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex.
   Biochem Biophys Res Commun. 2024;706:149728.
   

   >> Share

   
   

   
   Biochemistry (Mosc)

4. GABDOULKHAKOVA AG, Mingaleeva RN, Romozanova AM, Sagdeeva AR, et al
   Immunology of SARS-CoV-2 Infection.
   Biochemistry (Mosc). 2024;89:65-83.
   

   >> Share

   
   

   
   BMC Pediatr

5. HOSEININASAB A, Sinaei R, Bagheri MM, Ahmadipour M, et al
   Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes.
   BMC Pediatr. 2024;24:179.
   

   >> Share

   
   

   
   BMJ

6. WILKINSON E
   Covid inquiry: What we have learnt about Wales's response?
   BMJ. 2024;384:q608.
   

   >> Share

   
   

   
   Drug Saf

7. DOS SANTOS G, Devadiga R, Kim CS, Bang J, et al
   An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged
   Drug Saf. 2024 Mar 14. doi: 10.1007/s40264-024-01395.
   

   >> Share

   
   

   
   J Clin Microbiol

8. KONDGEN S, Oh D-Y, Thurmer A, Sedaghatjoo S, et al
   A robust, scalable, and cost-efficient approach to whole genome sequencing of RSV directly from clinical samples.
   J Clin Microbiol. 2024;62:e0111123.
   

   >> Share

   
   
9. PEAPER DR, Doern CD, Sharp S
   Proceedings of the Clinical Microbiology Open 2022-assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1).
   J Clin Microbiol. 2024;62:e0094123.
   

   >> Share

   
   
10. HICKMAN R, Nguyen J, Lee TD, Tyson JR, et al
    Rapid, high-throughput, cost-effective whole-genome sequencing of SARS-CoV-2 using a condensed library preparation of the Illumina DNA Prep kit.
    J Clin Microbiol. 2024;62:e0010322.
    

    >> Share

    
    

    
    J Immunol

11. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    

    >> Share

    
    

    
    J Infect

12. DOWELL AC, Tut G, Begum J, Bruton R, et al
    Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
    J Infect. 2023 Sep 1:S0163-4453(23)00465-6. doi: 10.1016/j.jinf.2023.
    

    >> Share

    
    

    
    J Infect Dis

13. ALI YM, Carnell GW, Fumagalli S, Mercurio D, et al
    Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.
    J Infect Dis. 2024;229:680-690.
    

    >> Share

    
    
14. RUDOLPH AE, Khan FL, Shah A, Singh TG, et al
    Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against symptomatic COVID-19 among immunocompetent individuals testing at a large US retail pharmacy.
    J Infect Dis. 2023 Oct 31:jiad474. doi: 10.1093.
    

    >> Share

    
    
15. BAY P, Loegel C, Ly A, Soulier A, et al
    Clinical Phenotypes and Molecular Characteristics of Respiratory Syncytial Virus in Adults: A Monocentric Prospective Study Between 2019 and 2022.
    J Infect Dis. 2024;229:728-732.
    

    >> Share

    
    
16. JENSEN TO, Grandits GA, Jain MK, Murray TA, et al
    Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
    J Infect Dis. 2024;229:671-679.
    

    >> Share

    
    
17. LI X, Zhou G, Sun X, Qu S, et al
    NLRP12 Senses the SARS-CoV-2 Membrane Protein and Promotes an Inflammatory Response.
    J Infect Dis. 2024;229:660-670.
    

    >> Share

    
    
18. ROSSLER A, Knabl L, Netzl A, Bante D, et al
    Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.
    J Infect Dis. 2024;229:644-647.
    

    >> Share

    
    
19. FINSTERER J
    Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment.
    J Infect Dis. 2024;229:918-919.
    

    >> Share

    
    
20. SCOTT N, Martinovich KM, Granland CM, Seppanen EJ, et al
    Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice.
    J Infect Dis. 2024 Mar 12:jiae069. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

21. SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
    Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
    J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
    

    >> Share

    
    
22. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    

    >> Share

    
    
23. WEN F, Yan Z, Chen G, Chen Y, et al
    Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
    J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
    

    >> Share

    
    

    
    JAMA

24. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    

    >> Share

    
    
25. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    

    >> Share

    
    
26. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    

    >> Share

    
    
27. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

28. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    

    >> Share

    
    

    
    N Engl J Med

29. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    

    >> Share

    
    

    
    PLoS One

30. GRACIOUS PD, Armah J, Boateng EA, Bam V, et al
    Expectations, experiences and challenges of nursing students using the virtual learning medium during the COVID-19 pandemic: A descriptive phenomenological study.
    PLoS One. 2024;19:e0299967.
    

    >> Share

    
    
31. FULHAM-MCQUILLAN H, O'Donovan R, Buckley CM, Crowley P, et al
    Exploring the needs and experiences of contact tracing staff during the COVID-19 pandemic in Ireland.
    PLoS One. 2024;19:e0298799.
    

    >> Share

    
    
32. BUTLER MJ, Chiuzan C, Ahn H, Gao M, et al
    Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults.
    PLoS One. 2024;19:e0286371.
    

    >> Share

    
    
33. SENJAM SS, Manna S, Goel G, Balhara YPS, et al
    Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
    PLoS One. 2024;19:e0299564.
    

    >> Share

    
    
34. SIMPSON E, Miller WC, Schmidt J, Borisoff J, et al
    Changes in functioning and health during the first 6-months of the COVID-19 pandemic among individuals with a spinal cord injury.
    PLoS One. 2024;19:e0299570.
    

    >> Share

    
    
35. MAJ A, Matynia M, Michalak N, Bis A, et al
    New in Town-An internet-based self-efficacy intervention for internal migrants: A randomized controlled trial.
    PLoS One. 2024;19:e0299638.
    

    >> Share

    
    
36. TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
    Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
    PLoS One. 2024;19:e0296812.
    

    >> Share

    
    
37. FREITAS DHM, Costa ELV, Zimmermann NA, Gois LSO, et al
    Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves.
    PLoS One. 2024;19:e0299607.
    

    >> Share

    
    
38. SINTO R, Lie KC, Setiati S, Suwarto S, et al
    Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital.
    PLoS One. 2024;19:e0297405.
    

    >> Share

    
    
39. ROUCOUX G, Thonon F, Zucman D, Rey D, et al
    Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
    PLoS One. 2024;19:e0295223.
    

    >> Share

    
    
40. GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
    Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
    PLoS One. 2024;19:e0300198.
    

    >> Share

    
    
41. PESTANA D, Moura K, Moura C, Mouliakis T, et al
    The impact of COVID-19 workload on psychological distress amongst Canadian intensive care unit healthcare workers during the 1st wave of the COVID-19 pandemic: A longitudinal cohort study.
    PLoS One. 2024;19:e0290749.
    

    >> Share

    
    
42. ZHANG X, Han X, Chen B, Fu X, et al
    Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
    PLoS One. 2024;19:e0289255.
    

    >> Share

    
    
43. SHERMAN SA, Quinn TD, Bock BC, Braun TD, et al
    Perceived delivery of essential yoga properties within in-person and remote weight loss maintenance interventions.
    PLoS One. 2024;19:e0300105.
    

    >> Share

    
    
44. POOL M, Sorsdahl K, Myers B, van der Westhuizen C, et al
    The prevalence of and factors associated with depressive and anxiety symptoms during the COVID-19 pandemic among healthcare workers in South Africa.
    PLoS One. 2024;19:e0299584.
    

    >> Share

    
    
45. MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
    COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
    PLoS One. 2024;19:e0299568.
    

    >> Share

    
    
46. MAMRATH S, Greenfield M, Fernandez Turienzo C, Fallon V, et al
    Experiences of postpartum anxiety during the COVID-19 pandemic: A mixed methods study and demographic analysis.
    PLoS One. 2024;19:e0297454.
    

    >> Share

    
    
47. MADDEN D
    Mental health in Ireland during the Covid pandemic: Evidence from two longitudinal surveys.
    PLoS One. 2024;19:e0279526.
    

    >> Share

    
    
48. RAMIREZ-MARTINEZ FR, Villanos MT, Sharma S, Leiner M, et al
    Variations in anxiety and emotional support among first-year college students across different learning modes (distance and face-to-face) during COVID-19.
    PLoS One. 2024;19:e0285650.
    

    >> Share

    
    
49. PANG Y, Robbs C, Wang J
    A longitudinal study of the COVID-19 pandemic impact on mental health in ophthalmic personnel and students.
    PLoS One. 2024;19:e0300144.
    

    >> Share

    
    
50. LI H, Wang C
    MIS-Net: A deep learning-based multi-class segmentation model for CT images.
    PLoS One. 2024;19:e0299970.
    

    >> Share

    
    
51. ROSMARIN DH, Pirutinsky S
    Response to anxiety treatment before, during, and after the COVID-19 pandemic.
    PLoS One. 2024;19:e0296949.
    

    >> Share

    
    
52. DEUTER D, Hense K, Kunkel K, Vollmayr J, et al
    SARS-CoV2 evokes structural brain changes resulting in declined executive function.
    PLoS One. 2024;19:e0298837.
    

    >> Share

    
    
53. HEIDECKE J, Fuhrmann J, Barbarossa MV
    A mathematical model to assess the effectiveness of test-trace-isolate-and-quarantine under limited capacities.
    PLoS One. 2024;19:e0299880.
    

    >> Share

    
    
54. MALIK H, Anees T
    Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.
    PLoS One. 2024;19:e0296352.
    

    >> Share

    
    
55. JUTTLA PK, Ndiritu M, Milliano F, Odongo AO, et al
    Knowledge, attitudes and practices towards COVID-19 among healthcare workers: A cross-sectional survey from Kiambu County, Kenya.
    PLoS One. 2024;19:e0297335.
    

    >> Share

    
    
56. BOAS H, Havdal LB, Stordal K, Dollner H, et al
    No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway.
    PLoS One. 2024;19:e0298104.
    

    >> Share

    
    
57. MARTINEZ-SANCHEZ JL, Zequeira Larios C, Hernandez Ramirez F
    Affectation of COVID-19 pandemic on the use and abundance of wild resources in Tabasco, Mexico: A qualitative assessment.
    PLoS One. 2024;19:e0299744.
    

    >> Share

    
    
58. SCHUMACHER J, Kuhne L, Brussermann S, Geisler B, et al
    COVID-19 isolation and quarantine orders in Berlin-Reinickendorf (Germany): How many, how long and to whom?
    PLoS One. 2024;19:e0271848.
    

    >> Share

    
    
59. SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
    Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
    PLoS One. 2024;19:e0299141.
    

    >> Share

    
    
60. DUAN S, Wang Y, Kotanko P, Zhang H, et al
    Network analysis of spread of SARS-CoV-2 within dialysis clinics: A multi-center network analysis.
    PLoS One. 2024;19:e0299855.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

61. CAHUANTZI R, Lythgoe KA, Hall I, Pellis L, et al
    Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods.
    Proc Natl Acad Sci U S A. 2024;121:e2317284121.
    

    >> Share

    
    

    
    Vaccine

62. ST-LOUIS P, Martin C, Khatri V, Bourgault S, et al
    Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice.
    Vaccine. 2024 Mar 8:S0264-410X(24)00222-6. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
63. LUISI M, Geana MV, Pei J
    Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination.
    Vaccine. 2024 Mar 8:S0264-410X(24)00275-5. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
64. 
    Expression of Concern: "Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine" [Vaccine [33/1], 1 January 2015, Pages 108-116].
    Vaccine. 2024;42:1851.
    

    >> Share

    
    

    
    Virology

65. LIU J, Gao L, Zhou N, Jiang Z, et al
    p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
    Virology. 2024;593:110018.
    

    >> Share

    
    
66. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    

    >> Share

    
    
67. SAIKIA BK, Roy K, Konwar R
    Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
    Virology. 2024;593:110036.
    

    >> Share

    
    

    
    Virus Res

68. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share